Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Tumor Lysis Syndrome 1Lymphoma 1Leukemia 1Inflammation 1Hyperuricemia 1Gout 1Cardiovascular Diseases 1Arthritis 1

Interventions

Nutrition Assessment 2Collagenases 2upadacitinib 1tocilizumab 1Vaccines 1Transcutaneous Electric Nerve Stimulation 1Saline Solution 1Resistance Training 1Omeprazole 1Naproxen 1Melphalan 1Lysine Acetyltransferase 5 1Injections, Intra-Articular 1Immune Checkpoint Inhibitors 1Herpes Zoster Vaccine 1Febuxostat 1Exercise Therapy 1Colchicine 1Cari-D-Tect 1Arthroplasty, Replacement, Shoulder 1Arthroplasty, Replacement, Elbow 1Allopurinol 1Adalimumab 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Arthritis × Febuxostat × Clear all
NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡